174

Part II Nutrition Assessment, Consequences, and Implications

. 4. Kim JC, Kalantar-Zadeh K, Kopel JD. Frailty and pro- tein-energy wasting in elderly patients with end stage kidney disease. J Am Soc Nephrol. 2013;24:337-351.

5. National Kidney Foundation. Kidney Disease Out- comes Quality Initiative clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(suppl 1):S1- S266.

6. Daniel KM, Cason CL. Estimating glomerular filtration rate in the elderly. J Nurse Pract. 2007;3:242-244.

7. Kopple JD, Massry SG, eds. Nutritional Management of Renal Disease. 2nd ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 2012.

8. Mitch WE, Klahr S, eds. Handbook of Nutrition and the Kidney. 4th ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 2010.

9. National Kidney Foundation. Kidney Disease Out- comes Quality Initiative. Clinical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis. 2000;35(suppl 2):S1-S140. www.kidney.org/sites /default/files/docs/kdoqi2000nutritiongl.pdf. Accessed December 29, 2015.

10. Academy of Nutrition and Dietetics. Evidence Analy- sis Library. Chronic kidney disease evidenced-based nutrition practice guideline. www.andeal.org. Accessed December 29, 2015.

11. Kim JC, Kalantar-Zadeh K, Kopple JD. Frailty and pro- tein-energy wasting in elderly patients with end stage kidney disease. Jr Am Soc Neph. 2013;24:337-351.

12. Sprague SM, Lerrna E, McCormmick D, Abraham M, Batlie D. Suppression of parathyroid hormone secretion in hemodialysis patients: comparison of paricalcitol with calcitriol. Am J Kidney Dis. 2001;38: 551-556.

13. Uhig K, Berns JS, Kestenbaum B, Kumar R, Lenard MB, Martin KJ, Sprague SM, Goldfarb S. KDOQI US Commentary on the 2009 KDIGO Clinical Practice Guideline: the diagnosis, evaluation and treatment of CKD-mineral and bone disorder (CKD-MBD). Am J Kidney Dis. 2010;55:773-799.

14. Block G, Port G. Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in manage- ment. Am J Kidney Dis. 2000;35:1226-1237.

15. Kliger A, Foley R, Goldfarb D, Goldstein S, Johansen K, Singh A, Szczech L. KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for Ane- mia in CKD. Am J Kidney Dis. 2013;62(5):849-859. www.kidney.org/sites/default/files/docs/kdoqi_com mentary_on_kdigo_anemia.pdf. Accessed January 12, 2015.

16. The MDRD Study Group. Reduction of dietary protein and phosphorus in the Modification of Diet in Renal Disease Feasibility Study. J Am Diet Assoc. 1994;94:986-990.

17. National Kidney Foundation. Kidney Disease Out- comes Quality Initiative Clinical Practice Guidelines for managing dyslipidemias in chronic kidney disease. Am J Kidney Disease. 2003;41(suppl 3):S1-S91. www. kidney.org/sites/default/files/docs/ajkd_dyslipidemia_ gls.pdf. Accessed December 29, 2015.

18. Beindorff ME, Ulerich JM. Nutrition management of the adult renal transplant patient. In: Byham-Gray L, Stover J, Wiesen K, eds. A Clinical Guide to Nutrition Care in Kidney Disease. 2nd ed. Chicago, IL: Academy of Nutrition and Dietetics; 2013.